Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 44 citing articles:

Linking the cerebellum to Parkinson disease: an update
Tianbai Li, Weidong Le, Joseph Jankovic
Nature Reviews Neurology (2023) Vol. 19, Iss. 11, pp. 645-654
Closed Access | Times Cited: 41
Functional brain networks in the evaluation of patients with neurodegenerative disorders
Matej Perovnik, Tomaž Rus, Katharina A. Schindlbeck, et al.
Nature Reviews Neurology (2022) Vol. 19, Iss. 2, pp. 73-90
Closed Access | Times Cited: 48
Inflammation, Dopaminergic Brain and Bilirubin
Sri Jayanti, Camilla Dalla Verde, Claudio Tiribelli, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11478-11478
Open Access | Times Cited: 18
Associations of Triglycerides and Atherogenic Index of Plasma with Brain Structure in the Middle-Aged and Elderly Adults
Xixi Chen, Yujia Bao, Jiahao Zhao, et al.
Nutrients (2024) Vol. 16, Iss. 5, pp. 672-672
Open Access | Times Cited: 5
Meso-cortical pathway damage in cognition, apathy and gait in cerebral small vessel disease
Hao Li, Mina A. Jacob, Mengfei Cai, et al.
Brain (2024) Vol. 147, Iss. 11, pp. 3804-3816
Open Access | Times Cited: 5
Neural alterations underlying executive dysfunction in Parkinson’s Disease: a systematic review and coordinate-based meta-analysis of functional neuroimaging studies.
Eleonora Arrigoni, Paola Antoniotti, Virginia Bellocchio, et al.
Ageing Research Reviews (2024) Vol. 95, pp. 102207-102207
Open Access | Times Cited: 5
Health Risks of Mercury
Ayesha Zafar, Sadia Javed, Nadia Akram, et al.
Earth and environmental sciences library (2024), pp. 67-92
Closed Access | Times Cited: 5
Neurovascular coupling alteration in drug-naïve Parkinson's disease: The underlying molecular mechanisms and levodopa's restoration effects
Chenqing Wu, Haoting Wu, Cheng Zhou, et al.
Neurobiology of Disease (2024) Vol. 191, pp. 106406-106406
Open Access | Times Cited: 4
A study on the exploration of mild cognitive impairment in Parkinson’s disease based on decision-making cognitive computing
Shouqiang Huang, Kai Li, Chen Wang, et al.
Frontiers in Neuroscience (2025) Vol. 18
Open Access
Executive dysfunction in Parkinson's disease: From neurochemistry to circuits, genetics and neuroimaging
Shuyan Tong, Ruiwen Wang, Hui‐Hua Li, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111272-111272
Closed Access
Resting‐State Functional MRI Regional Homogeneity Correlates With Motor Scores in Parkinson's Disease
Wei Dai, Zhe Li, Hao Lin, et al.
Journal of Neuroimaging (2025) Vol. 35, Iss. 1
Closed Access
Parkinson's disease and glucose metabolism impairment
Liangjing Chen, Chunyu Wang, Lixia Qin, et al.
Translational Neurodegeneration (2025) Vol. 14, Iss. 1
Open Access
Serum glial cell line-derived neurotrophic factor (GDNF) a potential biomarker of executive function in Parkinson’s disease
Shuyan Tong, Rui-Wen Wang, Qian Li, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 9
A review of the neurotransmitter system associated with cognitive function of the cerebellum in Parkinson’s disease
Xi Chen, Yuhu Zhang
Neural Regeneration Research (2023) Vol. 19, Iss. 2, pp. 324-330
Open Access | Times Cited: 8
Mild cognitive impairment among LRRK2 and GBA1 patients with Parkinson's disease
Avner Thaler, Vered Livne, Einat Rubinstein, et al.
Parkinsonism & Related Disorders (2024) Vol. 123, pp. 106970-106970
Closed Access | Times Cited: 2
Developmental exposure to methylmercury and ADHD, a literature review of epigenetic studies
Tao Ke, Alexey A. Tinkov, Antoly V Skalny, et al.
Current Zoology (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 13
Inorganic Nanomaterial for Biomedical Imaging of Brain Diseases
Wenxian Du, Lingling Zhou, Qiang Zhang, et al.
Molecules (2021) Vol. 26, Iss. 23, pp. 7340-7340
Open Access | Times Cited: 12
Scale-Free Functional Brain Networks Exhibit Increased Connectivity, Are More Integrated and Less Segregated in Patients with Parkinson’s Disease following Dopaminergic Treatment
Orestis Stylianou, Zalan Kaposzta, Akos Czoch, et al.
Fractal and Fractional (2022) Vol. 6, Iss. 12, pp. 737-737
Open Access | Times Cited: 8
Quantifying cerebral blood flow changes using arterial spin labeling: A comparative study of idiopathic rapid eye movement sleep behavior disorder and Parkinson's disease
Yuqi Zhi, Mingshen Chen, Chunshan Zhou, et al.
Magnetic Resonance Imaging (2024) Vol. 109, pp. 158-164
Closed Access | Times Cited: 1
Two-week Computerized Cognitive Training Affects Resting-State Electroencephalographic Rhythms in Parkinson’s Disease Patients with Cognitive Deficits
Roberta Lizio, Claudio Del Percio, Giuseppe Noce, et al.
(2024)
Open Access | Times Cited: 1
Diagnostic Sensitivity and Symptomatic Relevance of Dopamine Transporter Imaging and Myocardial Sympathetic Scintigraphy in Patients with Dementia with Lewy Bodies
Zhihui Tang, Shigeki Hirano, Yume Koizumi, et al.
Journal of Alzheimer s Disease (2024) Vol. 100, Iss. 1, pp. 127-137
Open Access | Times Cited: 1
Neuroenergetic alterations in neurodegenerative diseases: A systematic review and meta-analysis of in vivo 31P-MRS studies
Yinghua Jing, Alexa Haeger, Fawzi Boumezbeur, et al.
Ageing Research Reviews (2024) Vol. 101, pp. 102488-102488
Open Access | Times Cited: 1
Salidroside improves cognitive function in Parkinson’s disease via Braf-mediated mitogen‑activated protein kinase signaling pathway
Shujin Lu, Niu Ji, Wei Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116968-116968
Open Access | Times Cited: 1
Psychosis in Parkinson’s Disease: Looking Beyond Dopaminergic Treatments
Milagros Rojas, Mervin Chávez-Castillo, Pablo Durán, et al.
Current Pharmaceutical Design (2022) Vol. 28, Iss. 33, pp. 2725-2741
Closed Access | Times Cited: 7
Abnormalities of cerebral blood flow and the regional brain function in Parkinson’s disease: a systematic review and multimodal neuroimaging meta-analysis
Hao Xie, Yang Yang, Qian Sun, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top